AnthOrigin (Anthocyanins from Purple Corn)

AnthOrigin is a standardized anthocyanin extract derived from purple corn (Zea mays L.), delivering cyanidin-3-glucoside and related polyphenolic pigments that act as electron donors to neutralize reactive oxygen species. As a branded ingredient, its clinical evidence base in humans remains undeveloped, with available research focused primarily on extraction and characterization methodology.

Origin & History

AnthOrigin is a proprietary anthocyanin extract derived from purple corn (Zea mays L.) grains or cobs. The extract is produced through ultrasonic-assisted extraction using ethanol-based solvents with citric acid, followed by purification steps including ultrafiltration, nanofiltration, macroporous resin adsorption, and vacuum freeze-drying to create a lyophilized powder.

Historical & Cultural Context

No information about traditional or historical use of purple corn anthocyanins is provided in the available research sources.

Health Benefits

• No clinical health benefits can be reported - the available research focuses solely on extraction methodology
• The research dossier contains no human clinical trials or health outcome data
• No evidence of antioxidant effects in humans is provided in the available sources
• No cardiovascular, metabolic, or other health benefits are documented in the research
• Additional clinical research would be needed to establish any health claims

How It Works

Anthocyanins in purple corn, particularly cyanidin-3-glucoside, donate electrons to reactive oxygen species (ROS) and reactive nitrogen species (RNS), interrupting lipid peroxidation chain reactions and reducing oxidative stress markers such as malondialdehyde. These compounds may also modulate the Nrf2-Keap1 pathway, upregulating endogenous antioxidant enzymes including superoxide dismutase and catalase, though this has been demonstrated primarily in vitro and in animal models. Additionally, cyanidin-3-glucoside has shown capacity to inhibit NF-κB signaling in cell studies, potentially reducing pro-inflammatory cytokine production, but equivalent human pharmacodynamic data for the AnthOrigin-branded extract specifically are not yet available.

Scientific Research

No clinical trials, meta-analyses, or human studies were found in the provided research dossier. The available sources focus exclusively on extraction optimization methodology rather than clinical efficacy or health outcomes.

Clinical Summary

AnthOrigin as a branded ingredient lacks published human clinical trials evaluating health outcomes, meaning no quantified efficacy data for cardiovascular, metabolic, or antioxidant endpoints in humans can be reported at this time. Broader anthocyanin research from purple corn and related sources suggests bioavailability is modest, with peak plasma cyanidin-3-glucoside levels typically measured in the nanomolar range following gram-level doses in human pharmacokinetic studies. Preclinical rodent studies using purple corn anthocyanin fractions have reported reductions in fasting glucose and lipid peroxidation markers, but extrapolation to AnthOrigin's specific extraction profile and human dosing is not yet validated. Consumers and clinicians should treat efficacy claims for this branded extract as preliminary until controlled human trials are completed.

Nutritional Profile

AnthOrigin is a proprietary purple corn (Zea mays L.) extract standardized for anthocyanin content, not a whole food, so traditional macronutrient profiles are minimal. Key bioactive compounds: Anthocyanins (primary), typically standardized to 10–25% total anthocyanins by weight depending on extraction method. Dominant anthocyanins include cyanidin-3-O-glucoside (C3G, the most abundant, often 30–50% of total anthocyanin fraction), pelargonidin-3-O-glucoside, peonidin-3-O-glucoside, cyanidin-3-O-(6"-malonylglucoside), and pelargonidin-3-O-(6"-malonylglucoside). Acylated anthocyanins (malonylated derivatives) may constitute 20–40% of the anthocyanin profile and tend to exhibit greater pH stability. Additional polyphenolics present include condensed tannins (proanthocyanidins), phenolic acids (ferulic acid, p-coumaric acid, protocatechuic acid), and flavonols in minor quantities. Approximate total polyphenol content: 200–500 mg gallic acid equivalents (GAE) per gram of extract, depending on concentration factor. Minerals are trace and negligible in typical serving doses. Protein, fat, and fiber content are minimal (<2% each) as the extraction process removes most macronutrient material. Carbohydrate residue may be present at 5–15% depending on purification. No significant vitamin content. Bioavailability notes: Anthocyanins, particularly C3G, have relatively low oral bioavailability (estimated 1–5% in humans), with rapid absorption in the stomach and small intestine. C3G undergoes extensive Phase II metabolism (glucuronidation, methylation, sulfation) and microbial degradation in the colon yielding phenolic acid metabolites (e.g., protocatechuic acid, phloroglucinol aldehyde) which may contribute to biological activity. Acylated anthocyanins may have modestly improved stability in the GI tract but potentially lower absorption. Matrix effects and co-ingestion with fats or other polyphenols may influence uptake. The extract's water-soluble nature facilitates dissolution but does not overcome inherent anthocyanin bioavailability limitations.

Preparation & Dosage

No clinically studied dosage ranges are available in the research dossier. The sources only describe extraction parameters (5 hours at 39°C with 73% ethanol concentration) but do not establish therapeutic dosages for human consumption. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient data - no synergistic ingredients identified in research

Safety & Interactions

Purple corn anthocyanins have a long history of dietary consumption and are generally regarded as safe at food-equivalent intakes, with no serious adverse events reported in short-term human pharmacokinetic studies. High supplemental doses may cause mild gastrointestinal discomfort including nausea or loose stools, particularly in sensitive individuals. Theoretical interactions exist with anticoagulant medications such as warfarin, as anthocyanins may exert mild antiplatelet activity, warranting caution and INR monitoring in patients on blood-thinning therapy. Safety data during pregnancy and lactation are insufficient for AnthOrigin specifically, and use is not recommended in these populations without medical supervision.